Literature DB >> 17343337

Sialylation and fucosylation of cancer-associated prostate specific antigen.

M M Kosanović1, M M Janković.   

Abstract

PURPOSE: To examine sialylation and fucosylation of prostate cancer-associated prostate-specific antigen (PCa PSA) from localized prostate cancer and from metastatic prostate cancer, as relevant indicators of tumour stage-dependent microheterogeneity of its oligosaccharide chain.
MATERIALS AND METHODS: Sera and urine were collected from a group of consenting patients and used as source of the examined PSA. Lectin-affinity chromatography was performed on the columns with immobilized sialic acid-specific lectins Sambucus nigra agglutinin (SNA) and Maackia amurensis lectin (MAA), and fucose-specific lectins Aleuria aurantia agglutinin (AAA) and Ulex europaeus agglutinin (UEA). PSA elution from the corresponding columns was monitored by measuring immunoreactivity to free (f) PSA form.
RESULTS: The results of lectin affinity chromatographies of PCa PSA indicated distinct and high microheterogeneity of its oligosaccharide chain in respect to the presence of glycoforms differing in the position and the type of linkage of sialic acid or fucose, as well as alterations related to the examined PSA source (localized or metastatic prostate cancer).
CONCLUSION: The observed decrease in SNA reactivity to metastatic PCa PSA in comparison with PCa PSA from localized prostate cancer may be of interest in the monitoring of response to therapy and scoring of its metastatic potential.

Entities:  

Year:  2005        PMID: 17343337

Source DB:  PubMed          Journal:  J BUON        ISSN: 1107-0625            Impact factor:   2.533


  9 in total

1.  Overexpression of α (1,6) fucosyltransferase associated with aggressive prostate cancer.

Authors:  Xiangchun Wang; Jing Chen; Qing Kay Li; Sarah B Peskoe; Bai Zhang; Caitlin Choi; Elizabeth A Platz; Hui Zhang
Journal:  Glycobiology       Date:  2014-06-05       Impact factor: 4.313

2.  Evaluation of molecular species of prostate-specific antigen complexed with immunoglobulin M in prostate cancer and benign prostatic hyperplasia.

Authors:  Sanja Goč; Miroslava Janković
Journal:  Dis Markers       Date:  2013-12-03       Impact factor: 3.434

Review 3.  Recent Advances in Glycoproteomic Analysis by Mass Spectrometry.

Authors:  Suttipong Suttapitugsakul; Fangxu Sun; Ronghu Wu
Journal:  Anal Chem       Date:  2019-11-04       Impact factor: 6.986

4.  Improvement of Prostate Cancer Diagnosis by Detecting PSA Glycosylation-Specific Changes.

Authors:  Esther Llop; Montserrat Ferrer-Batallé; Sílvia Barrabés; Pedro Enrique Guerrero; Manel Ramírez; Radka Saldova; Pauline M Rudd; Rosa N Aleixandre; Josep Comet; Rafael de Llorens; Rosa Peracaula
Journal:  Theranostics       Date:  2016-05-24       Impact factor: 11.556

5.  Comparative Study of Blood-Based Biomarkers, α2,3-Sialic Acid PSA and PHI, for High-Risk Prostate Cancer Detection.

Authors:  Montserrat Ferrer-Batallé; Esther Llop; Manel Ramírez; Rosa Núria Aleixandre; Marc Saez; Josep Comet; Rafael de Llorens; Rosa Peracaula
Journal:  Int J Mol Sci       Date:  2017-04-17       Impact factor: 5.923

Review 6.  The Diverse Contributions of Fucose Linkages in Cancer.

Authors:  Tyler S Keeley; Shengyu Yang; Eric Lau
Journal:  Cancers (Basel)       Date:  2019-08-24       Impact factor: 6.639

7.  Analysis of Urinary Prostate-Specific Antigen Glycoforms in Samples of Prostate Cancer and Benign Prostate Hyperplasia.

Authors:  Chun-Jen Hsiao; Tzong-Shin Tzai; Chein-Hung Chen; Wen-Horng Yang; Chung-Hsuan Chen
Journal:  Dis Markers       Date:  2016-03-15       Impact factor: 3.434

8.  Study of glycosylation of prostate-specific antigen secreted by cancer tissue-originated spheroids reveals new candidates for prostate cancer detection.

Authors:  Hiroko Ideo; Jumpei Kondo; Taisei Nomura; Norio Nonomura; Masahiro Inoue; Junko Amano
Journal:  Sci Rep       Date:  2020-02-17       Impact factor: 4.379

9.  Carcinoembryonic antigen as a specific glycoprotein ligand of rBC2LCN lectin on pancreatic ductal adenocarcinoma cells.

Authors:  Tomoaki Furuta; Tatsuya Oda; Kayo Kiyoi; Ozawa Yusuke; Sota Kimura; Ko Kurimori; Yoshihiro Miyazaki; Yang Yu; Kinji Furuya; Yoshimasa Akashi; Osamu Shimomura; Hiroaki Tateno
Journal:  Cancer Sci       Date:  2021-06-29       Impact factor: 6.716

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.